Furthermore, a 5′RACE assay on the RNA extracted from the treated xenograft tumour suggests specific survivin mRNA cleavage at the expected siRNA cut site through the Argonaute2 (Ago2) mechanism (Fig. 1c). This evidence concerns the gene BIRC5 and neoplasm.